Jason Haas
CIK 1883821 · Chief Financial Officer · last filed 2026-06-15
Jason Haas is a Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for LGND, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.69M
3
20
-$1.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LGND | Director | 11,442 | $293.15 | $3.35M | -$1.65M | 6 | 2026-06-15 |
| ODTX | Chief Financial Officer | 62,908 | $21.17 | $1.33M | $20.0K | 1 | 2026-05-11 |
| Syros Pharmaceuticals, Inc. (SYRS) Delisted | Chief Financial Officer | 0 | $0.00 | $0 | $132.3K | 10 | 2024-11-20 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | LGND | Mixed | −2,461 | -$1.45M | EDGAR |
| 2026-06-12 | LGND | Notice (144) | −6,461 | -$1.65M | EDGAR |
| 2026-06-09 | LGND | Grant (A) | +836 | $0 | EDGAR |
| 2026-05-11 | ODTX | Buy (P) | +1,000 | $20.0K | EDGAR |
| 2025-06-10 | LGND | Grant (A) | +1,209 | $0 | EDGAR |
| 2024-11-20 | Syros Pharmaceuticals, Inc. (SYRS) Delisted | Sell (S) | −137,803 | -$29.0K | EDGAR |
| 2024-11-18 | — | Notice (144) | −37,803 | -$8.7K | EDGAR |
| 2024-11-18 | — | Notice (144) | −100,000 | -$20.3K | EDGAR |
| 2024-11-04 | Syros Pharmaceuticals, Inc. (SYRS) Delisted | Mixed | +13,251 | -$11.8K | EDGAR |
| 2024-09-12 | Syros Pharmaceuticals, Inc. (SYRS) Delisted | Buy (P) | +100,000 | $161.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.